marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q1
added 05-10-2023
Syneos Health Balance Sheet 2011-2024 | SYNH
Annual Balance Sheet Syneos Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
2.71 B | 2.67 B | 2.44 B | 2.63 B | 2.65 B | 395 M | 417 M | 294 M | 498 M | 513 M | - |
Long Term Debt |
2.78 B | 2.9 B | 2.55 B | 2.74 B | 2.95 B | 486 M | 472 M | 415 M | 587 M | 586 M | - |
Long Term Debt Current |
43.1 M | 42.1 M | 38.1 M | 50.1 M | 25 M | 11.9 M | 29.8 M | 4.25 M | - | - | - |
Total Non Current Liabilities |
- | 2.97 B | 2.91 B | 2.9 B | 3.1 B | 520 M | 519 M | 473 M | 639 M | 631 M | - |
Total Current Liabilities |
1.65 B | 1.58 B | 1.52 B | 1.5 B | 1.16 B | 467 M | 475 M | 380 M | - | - | - |
Total Liabilities |
4.82 B | 4.82 B | 4.42 B | 4.4 B | 4.26 B | 987 M | 994 M | 853 M | 957 M | 941 M | - |
Deferred Revenue |
868 M | 35.1 M | 697 M | 777 M | 559 M | 278 M | 311 M | 247 M | 207 M | 200 M | - |
Retained Earnings |
-13 M | - | -341 M | -459 M | -370 M | -230 M | -301 M | -217 M | -189 M | -147 M | - |
Total Assets |
8.24 B | 8.06 B | 7.45 B | 7.25 B | 7.29 B | 1.29 B | 1.21 B | 1.25 B | 1.23 B | 1.26 B | - |
Cash and Cash Equivalents |
106 M | 272 M | 164 M | 156 M | 321 M | 102 M | 85 M | 126 M | 97 M | 81.4 M | - |
Book Value |
3.41 B | 3.24 B | 3.03 B | 2.86 B | 3.02 B | 301 M | 217 M | 392 M | 276 M | 317 M | - |
Total Shareholders Equity |
3.41 B | 3.24 B | 3.03 B | 2.86 B | 3.02 B | 301 M | 217 M | 392 M | 276 M | 317 M | - |
All numbers in USD currency
Quarterly Balance Sheet Syneos Health
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
2.61 B | 2.61 B | - | - | 2.91 B | 2.78 B | 2.89 B | 2.86 B | 2.86 B | 2.9 B | 2.9 B | 2.9 B | 2.9 B | 2.55 B | 2.55 B | 2.55 B | 2.55 B | 2.74 B | 2.74 B | 2.74 B | 2.74 B | 2.95 B | 2.95 B | 2.95 B | 2.95 B | 486 M | 486 M | 486 M | 486 M | 472 M | 472 M | 472 M | 472 M | 412 M | 415 M | 415 M | 415 M | 587 M | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
4.64 B | 4.7 B | - | - | 5 B | 4.82 B | 4.9 B | 4.78 B | 4.72 B | 4.82 B | 4.82 B | 4.82 B | 4.82 B | 4.42 B | 4.42 B | 4.42 B | 4.42 B | 4.4 B | 4.4 B | 4.4 B | 4.4 B | 4.26 B | 4.26 B | 4.26 B | 4.26 B | 987 M | 987 M | 987 M | 987 M | 994 M | 994 M | 994 M | 994 M | 849 M | 853 M | 853 M | 853 M | 957 M | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
859 M | 924 M | - | - | 892 M | 868 M | 820 M | 802 M | 773 M | 793 M | 793 M | 793 M | 793 M | 697 M | 697 M | 697 M | 697 M | 777 M | 777 M | 777 M | 777 M | 559 M | 511 M | 299 M | 288 M | 278 M | 278 M | 278 M | 278 M | 311 M | 311 M | 311 M | 311 M | 247 M | 247 M | 247 M | 247 M | 207 M | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
95.5 M | 168 M | - | - | -52.6 M | -13 M | -88.9 M | -167 M | -166 M | -180 M | -180 M | -180 M | -180 M | -341 M | -341 M | -341 M | -341 M | -459 M | -459 M | -459 M | -459 M | -370 M | -370 M | -370 M | -370 M | -230 M | -230 M | -230 M | -230 M | -301 M | -301 M | -301 M | -301 M | -217 M | -217 M | -217 M | -217 M | -189 M | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
8.1 B | 8.2 B | - | - | 8.3 B | 8.24 B | 8.22 B | 8.02 B | 7.95 B | 8.06 B | 8.06 B | 8.06 B | 8.06 B | 7.45 B | 7.45 B | 7.45 B | 7.45 B | 7.25 B | 7.25 B | 7.25 B | 7.25 B | 7.29 B | 7.29 B | 7.29 B | 7.29 B | 1.29 B | 1.29 B | 1.29 B | 1.29 B | 1.21 B | 1.21 B | 1.21 B | 1.21 B | 1.24 B | 1.25 B | 1.25 B | 1.25 B | 1.23 B | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
111 M | 112 M | - | - | 119 M | 106 M | 123 M | 261 M | 265 M | 272 M | 272 M | 272 M | 272 M | 164 M | 164 M | 164 M | 164 M | 154 M | 132 M | 172 M | 187 M | 321 M | 321 M | 321 M | 321 M | 102 M | 102 M | 102 M | 102 M | 85 M | 85 M | 85 M | 85 M | 126 M | 126 M | 126 M | 126 M | 97 M | - | - | - | 81.4 M | - | - | - | 71 M | - | - | - |
Book Value |
3.45 B | 3.5 B | - | - | 3.3 B | 3.41 B | 3.32 B | 3.24 B | 3.24 B | 3.24 B | 3.24 B | 3.24 B | 3.24 B | 3.03 B | 3.03 B | 3.03 B | 3.03 B | 2.86 B | 2.86 B | 2.86 B | 2.86 B | 3.02 B | 3.02 B | 3.02 B | 3.02 B | 301 M | 301 M | 301 M | 301 M | 217 M | 217 M | 217 M | 217 M | 392 M | 392 M | 392 M | 392 M | 276 M | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
3.45 B | 3.5 B | - | - | 3.3 B | 3.41 B | 3.32 B | 3.24 B | 3.24 B | 3.24 B | 3.24 B | 3.24 B | 3.24 B | 3.03 B | 3.03 B | 3.03 B | 3.03 B | 2.86 B | 2.86 B | 2.86 B | 2.86 B | 3.02 B | 3.02 B | 3.02 B | 3.02 B | 301 M | 301 M | 301 M | 301 M | 217 M | 217 M | 217 M | 217 M | 392 M | 392 M | 392 M | 392 M | 276 M | - | - | - | 317 M | - | - | - | 379 M | - | - | - |
All numbers in USD currency